Difference between revisions of "Xiong"
(Imported from Wikispaces) |
|||
| Line 1: | Line 1: | ||
| − | |||
| − | <span style=" | + | = <span style="font-size:x-large;"><span style="font-family: " open="" sans",="" arial,="" helvetica,="" "lucida="" sans="" unicode",="" sans-serif;="" vertical-align:="" baseline;"="">Hyperbaric oxygen for term newborns with hypoxic ischemic encephalopathy</span></span> = |
| − | |||
| − | + | <span style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 1.6em; vertical-align: baseline;">Protocol for a Cochrane Systematic Review</span> <span style="font-size: 120%;">The objective of this review is to determine the effects of therapeutic HBO (with or without hypothermia) on death and long-term neurodevelopmental disabilities in term newborn infants with HIE. Furthermore, the short-term medical effects and side effects of HBO will be studied.</span> | |
| − | + | * | |
| − | + | **<span style="font-size: 120%;">This protocol published in 2017 and no sign of the completed review.</span> | |
| − | |||
| − | |||
| − | |||
| − | <span style="color: #333333; font-family: | + | <span style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 1.6em; vertical-align: baseline;">Primary comparisons:</span> |
| − | |||
| − | |||
| − | |||
| − | |||
| − | <span style="font-size: | + | #<span style="font-size: 120%;">HBO versus supportive care;</span> |
| − | + | #<span style="font-size: 120%;">HBO versus hypothermia therapy;</span> | |
| − | + | #<span style="font-size: 120%;">HBO plus hypothermia versus hypothermia alone;</span> | |
| + | #<span style="font-size: 120%;">HBO plus erythropoietin versus erythropoietin alone.</span> | ||
| − | + | <span style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 1.6em; vertical-align: baseline;">Subgroup analyses were planned on the basis of:</span> | |
| − | <span style="background-color: #ffffff; color: #7c00ff; display: block; font-size: 26px; text-align: center;">'''[[ | + | #<span style="font-size: 120%;">severity of HIE (mild, moderate, severe)</span> |
| − | </span> | + | #<span style="font-size: 120%;">the therapeutic time window, by timing of commencement of the intervention (< 6 hours versus 6 hours to 7 days versus > 7 days);</span> |
| + | #<span style="font-size: 120%;">the peak pressure of HBO (< 2 ATA versus > 2ATA);</span> | ||
| + | #<span style="font-size: 120%;">the number of courses of HBO (single course versus multiple courses).</span> | ||
| + | |||
| + | <span style="font-size: 140%;">Citation</span> <span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Xiong T</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, </span><span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Li H</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, </span><span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Zhao J</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, </span><span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Dong W</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, </span><span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Qu Y</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, </span><span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Wu T</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, </span><span class="author" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Mu D</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">. </span><span class="articleTitle" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Hyperbaric oxygen for term newborns with hypoxic ischemic encephalopathy (Protocol)</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">. </span><span class="otherTitle" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">Cochrane Database of Systematic Reviews</span> <span class="vol" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">2011</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">, Issue </span><span class="citedIssue" style="color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px; vertical-align: baseline;">8</span><span style="background-color: #ffffff; color: #333333; font-family: 'Open Sans',Arial,Helvetica,'Lucida Sans Unicode',sans-serif; font-size: 15px;">. Art. No.: CD009248. DOI: 10.1002/14651858.CD009248.</span> <span style="display: block; text-align: center;"></span> | ||
| + | |||
| + | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | ||
| + | |||
| + | <span style="background-color: #ffffff; color: #7c00ff; display: block; font-size: 26px; text-align: center;">'''[[Cerebral_Palsy|BACK]]'''</span> | ||
Latest revision as of 02:01, 15 November 2020
Hyperbaric oxygen for term newborns with hypoxic ischemic encephalopathy
Protocol for a Cochrane Systematic Review The objective of this review is to determine the effects of therapeutic HBO (with or without hypothermia) on death and long-term neurodevelopmental disabilities in term newborn infants with HIE. Furthermore, the short-term medical effects and side effects of HBO will be studied.
-
- This protocol published in 2017 and no sign of the completed review.
Primary comparisons:
- HBO versus supportive care;
- HBO versus hypothermia therapy;
- HBO plus hypothermia versus hypothermia alone;
- HBO plus erythropoietin versus erythropoietin alone.
Subgroup analyses were planned on the basis of:
- severity of HIE (mild, moderate, severe)
- the therapeutic time window, by timing of commencement of the intervention (< 6 hours versus 6 hours to 7 days versus > 7 days);
- the peak pressure of HBO (< 2 ATA versus > 2ATA);
- the number of courses of HBO (single course versus multiple courses).
Citation , , , , , , . Hyperbaric oxygen for term newborns with hypoxic ischemic encephalopathy (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD009248. DOI: 10.1002/14651858.CD009248.
